Showing results (181-190 of 386) with videos related to

Sort By:
Pageof 39
Journal of Virology|July 7, 2018
Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus InteractionsGiulia Fabozzi, Andrew J Oler, Poching Liu, et al.
Virology|October 17, 2009
The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virusAmorsolo L Suguitan, Michael P Marino, Purvi D Desai, et al.
Communicable Diseases Intelligence (2018)|May 18, 2025
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2023Tanya R Diefenbach-Elstob, Olivia Lay, Tasoula Zakis, et al.
Mbio|October 27, 2022
Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in HumansTroy C Sutton, Elaine W Lamirande, Devanshi R Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2013
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesAudray K Harris, Joel R Meyerson, Yumiko Matsuoka, et al.
The Lancet. Respiratory Medicine|September 24, 2022
Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysisElenor Jones-Gray, Elizabeth J Robinson, Adam J Kucharski, et al.
Plos Medicine|September 14, 2006
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsAmorsolo L Suguitan, Josephine McAuliffe, Kimberly L Mills, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Influenza and Other Respiratory Viruses|December 1, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 monthsFrancesca L Mordant, Olivia H Price, Rajeev Rudraraju, et al.
The Journal of Infectious Diseases|February 13, 2009
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adultsRuth A Karron, Karen Callahan, Catherine Luke, et al.
Pageof 39